Atovaquone
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
81033-104 -
Package NDC
81033-104-22 -
Package NDC
81033-104-42 -
Package NDC
81033-104-50 -
Application number
ANDA212918 -
SPL ID
3edaf9cd-76b2-a531-e063-6294a90a7e1a -
SPL set ID
16b69156-e5de-c601-e063-6394a90afeae -
UNII
Y883P1Z2LT -
RxCUI
308429
What the source publishes
- Labeler
- Kesin Pharma
- Active ingredients
- Atovaquone
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Atovaquone",
"splId": "3edaf9cd-76b2-a531-e063-6294a90a7e1a",
"labels": [
{
"setId": "16b69156-e5de-c601-e063-6394a90afeae",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16b69156-e5de-c601-e063-6394a90afeae",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16b69156-e5de-c601-e063-6394a90afeae"
}
],
"routes": [
"ORAL"
],
"labeler": "Kesin Pharma",
"finished": true,
"packaging": [
{
"sample": false,
"description": "20 CUP, UNIT-DOSE in 1 CARTON (81033-104-22) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)",
"package_ndc": "81033-104-22",
"identifierStatus": "well-formed",
"marketing_start_date": "20250915"
},
{
"sample": false,
"description": "42 CUP, UNIT-DOSE in 1 CARTON (81033-104-42) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)",
"package_ndc": "81033-104-42",
"identifierStatus": "well-formed",
"marketing_start_date": "20240617"
},
{
"sample": false,
"description": "50 CUP, UNIT-DOSE in 1 CARTON (81033-104-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)",
"package_ndc": "81033-104-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20240617"
}
],
"productId": "81033-104_3edaf9cd-76b2-a531-e063-6294a90a7e1a",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "81033-104",
"deaSchedule": null,
"genericName": "Atovaquone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ATOVAQUONE",
"strength": "750 mg/5mL"
}
],
"applicationNumber": "ANDA212918",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240617",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175482",
"N0000175485"
],
"unii": [
"Y883P1Z2LT"
],
"rxcui": [
"308429"
],
"spl_set_id": [
"16b69156-e5de-c601-e063-6394a90afeae"
],
"pharm_class_epc": [
"Antimalarial [EPC]",
"Antiprotozoal [EPC]"
],
"manufacturer_name": [
"Kesin Pharma"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:81033-104_3edaf9cd-76b2-a531-e063-6294a90a7e1a"